Sam Quinones, "Dreamland: The True Tale of American's Opiate Epidemic" (Bloomsbury Press, 2015)

Summary

In the early 2000s, the press--at least in Boston, where I was living at the time--was full of shrill stories about drug-crazed addicts breaking into area pharmacies in search of something called "Oxycontin." I had no idea what Oxycontin was, but I was pretty sure there must be something remarkable about it if ordinary drug fiends were risking jail time and worse by robbing mom-and-pop drug stores to get it. As Sam Quinones explains in his remarkable book Dreamland: The True Tale of American's Opiate Epidemic (Bloomsbury Press, 2015), the Oxycontin crime wave was an early moment in the emergence of a full-blown Opiate epidemic in the United States. For many young doctors working in "pain management in the 90s and naughts, Oxycontin was remarkable indeed. It gave them just what their predecessors in the eternal fight against pain lacked: a supposedly non-addictive opium-based medication that they could prescribe far and wide without fear of hooking their patients on it. And with all the best intentions, prescribe it far and wide these doctors did. But it wasn't non-addictive at all; masses of patients become dependent. And not only them. Drug-users learned that "Oxy" afforded a wonderful high, and it became highly coveted "on the street." The rub was that this new "wonder drug" was either hard to get--unless you had access to a "Pill Mill"--and/or very expensive. So Oxycontin addicts got desperate. Some, like the ones the press was screaming about in Boston, stole the drug from the local CVS and the like. Most, however, turned to an old drug that was easier to get and cheaper: Black Tar Heroin from Mexico. In the wake of Oxycontin, Black Tar spread from the Southwest across much of the U.S., even to places like Western Massachusetts, where I live now and the heroin epidemic is in full, tragic swing.

Your Host

Marshall Poe

Marshall Poe is the founder and editor of the New Books Network. He can be reached at marshallpoe@newbooksnetwork.com.

View Profile